Observation of Italian Patients with Heart Failure Being Treated with Dapagliflozin in Clinical Practice

Trial Identifier:	D1699R00030
Sponsor:	AstraZeneca
Collaborator:	Fullcro s.r.l.
Start Date:	April 2022
Primary Completion Date:	April 2024
Study Completion Date:	April 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Italy, BS	Brescia, BS, Italy, 25123
Italy, CZ	Catanzaro, CZ, Italy, 88100
Italy, FG	Foggia, FG, Italy, 71122
Italy, FI	Firenze, FI, Italy, 50100
Italy, GE	Genova, GE, Italy, 16132
Italy, MB	Monza, MB, Italy, 20900
Italy, MI	Milano, MI, Italy, 20122
Italy, NA	Napoli, NA, Italy, 80131
Italy, RM	Roma, RM, Italy, 00163
Italy, RM	Roma, RM, Italy, 00189
Italy, TS	Trieste, TS, Italy, 34125

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company